Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma (Q83308745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

main subject

endometrial carcinoma

1 reference

inferred from title

author name string

Maria Honkavuori-Toivola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Anne Talvensaari-Mattila

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ylermi Soini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Taina Turpeenniemi-Hujanen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Markku Santala

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

21 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

935-941

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270451%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-012-0321-7

21 January 2020

exact match

0 references

cites work

Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions

1 reference

12 December 2020

Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma

1 reference

12 December 2020

Matrix metalloproteinases and tumor metastasis

1 reference

12 December 2020

Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro

1 reference

12 December 2020

The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters

1 reference

12 December 2020

High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma

1 reference

12 December 2020

Tumour invasion and matrix metalloproteinases.

1 reference

12 December 2020

Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

1 reference

12 December 2020

Tissue inhibitors of metalloproteases: regulation and biological activities

1 reference

12 December 2020

Tumor Cell Invasion Inhibited by TIMP-2

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines

1 reference

12 December 2020

Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer

1 reference

12 December 2020

Treatment options for advanced endometrial carcinoma

1 reference

12 December 2020

The role of matrix metalloproteinases-2, -7 and -9 and beta-catenin in high grade endometrial carcinoma

1 reference

12 December 2020

Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer

1 reference

12 December 2020

Controversies in the management of endometrial carcinoma

1 reference

12 December 2020

Structure and function of matrix metalloproteinases and TIMPs

1 reference

12 December 2020

Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form

1 reference

12 December 2020

High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.

1 reference

12 December 2020

TIMPs as multifacial proteins

1 reference

12 December 2020

Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer

1 reference

12 December 2020

Endometrial carcinoma

1 reference

12 December 2020

Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.

1 reference

12 December 2020

Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases

1 reference

12 December 2020

TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads

1 reference

12 December 2020

Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study.

1 reference

12 December 2020

MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma

1 reference

12 December 2020